ADAMTS13 and thrombotic thrombocytopenic purpura: Following the establishment of the assay method for VWF protease (ADAMTS13) activity in 1996 [11, 12], patients with TTP were reported in 1998 to show severely reduced ADAMTS13 activity [2, 3].